In-Depth Analysis of Mayo v. Prometheus: What it Means for the Future of Medical Diagnostic Patents
Please note: CPE credit is not available through Training Packs More information is available below Featuring (click image for more information):
Why You Should Attend: The Supreme Court unanimously held that claims directed to the relationship between the concentrations of blood metabolites and response to a therapeutic drug in two patents owned by Prometheus Laboratories, Inc. were unpatentable, stating that they "effectively claim the underlying laws of nature themselves." This is a reversal of the Federal Circuit's decision, which held that the claims did indeed encompass patentable subject matter. The Court also vacated the Fed Circuit's decision in the Myriad gene patents case, sending it back for reconsideration based on the guidance offered in the Mayo ruling. This landmark decision directly affects how universities approach patent decision making for diagnostic method patents, and will almost certainly impact the Myriad case, as well as a whole range of method claims surrounding other technologies. Indeed, the USPTO has instructed examiners to "continue to examine patent applications for compliance with section 101 using the existing Interim Bilski Guidance" along with some additional considerations based on the Supreme Court's ruling. (Find the full text memo here.) To help you make sense of the complex patentability issues raised by the decision, and to guide you in drafting future claims, we've scheduled this critical webinar. Our expert attorney will dissect the Court's decision and help you understand how to adjust your patent strategy in light of this development. BVR is pleased to partner with Kevin E. Noonan, PhD, author of the PatentDocs blog and a partner with McDonnell Boehnen Hulbert & Berghoff LLP, for this analytical 60-minute webinar. Agenda Dr. Noonan will:
Learning Objectives
Single Connection Policy Multi-User CPE Policy CPE Processing Fees may be bypassed by entering a valid, unused CPE Authorization Code (for single event purchasers) or by logging into BVR's website (for subscribers to BVR's Training Series). Get Unlimited Access to BVR's Webinar Calendar Training Passport/Training Passport Pro subscribers receive:
For more information on the Training Passport/Training Passport Pro or group discounts to single events for 5 or more people, contact BVR at sales@bvresources.com Continuing Education*: NASBA:Â 1 Credits CPE Credits for Unlimited Listeners CPE Information Prerequisites: Knowledge of Business Valuation
Training Packs BVR's Training Packs are an indispensable addition to any valuation reference library, or the perfect alternative when you cannot attend the session live. Each Training Pack is delivered approximately 2-4 weeks after the program has aired, and includes:
Please note, CPE is not available with Training Packs. |
|
BVR's Satisfaction Guarantee:
Business Valuation Resources offers a 100% money-back guarantee. If you are not completely satisfied with your conference experience, or have any concerns or complaints, you may contact Business Valuation Resources at (503) 291-7963, cs@bvresources.com or mail to BVR, LLC, 1000 SW Broadway, Suite 1200, Portland, OR 97205.